To include your compound in the COVID-19 Resource Center, submit it here.

Belinostat: Additional Phase I/II data

Additional data from 20 patients in the Phase II portion of the open-label Phase I/II PXD101-CLN-14 trial showed that belinostat plus doxorubicin

Read the full 228 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE